Study Demonstrates Percutaneous Tibial Nerve Stimulation Offers More Cost

Study Demonstrates Percutaneous Tibial Nerve Stimulation Offers More Cost

Filed under: drug abuse treatment outcome study

6, 2012 — /PRNewswire/ — Uroplasty, Inc. (NASDAQ:UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today highlighted results of a study that compared the …
Read more on Sacramento Bee

 

Cell Therapeutics Reports on Cooperative Group Sponsored Trial of Brostallicin

Filed under: drug abuse treatment outcome study

The authors concluded that in this study the combination of brostallicin and cisplatin showed promising activity in heavily pretreated metastatic triple-negative breast cancer patients and achieved its primary endpoint comparing favorably to other …
Read more on Sacramento Bee

 

Omeros Announces Encouraging Data from Phase 1 Clinical Trial for PDE10

Filed under: drug abuse treatment outcome study

In this successful SAD study, OMS824 was well tolerated and demonstrated linear pharmacokinetics, a long half-life consistent with once daily dosing and good systemic exposure that, at the highest dose administered, resulted in the expected … Omeros …
Read more on Sacramento Bee